References
- 1. Chieffo A, Foglieni C, Nodari RL, et al. Histopathology of clinical coronary restenosis in drug eluting versus bare metal stents. Am J Cardiol. 2009;104:1660-1667. doi:10.1016/j. amjcard.2009.07.041.
- 2. Suzuki N , Nanda H, Angiolillo DJ, et al. Assessment of potential realtionship between wall shear stress and sirolimus - eluting stent implantation in patients with diabetes mellitus. Int J Cardiovasc Imaging. 2008;24:357-364. doi 10.1007/s10554-007-9274-0.10.1007/s10554-007-9274-0
- 3. Oikava YJ, Costa M, Matsuno S, et al. Intravasculare ultrasound, angioscopic and histopathological characterisation of heterogenous patterns of restenosis after sirolimus eluting stents implantation: insights into potential thromborestenosis phenomenon. Eurointervention. 2010;6:380-387. doi:10.1016/j. jacc.2006.04.068.
- 4. Gijsen FJ, Oortamn RM, WentzellJ, et al. Usefulness of shear stress pattern in predicting neointima distribution in sirolimus eluting stents in coronary arteries. Am J Cardiol. 2003;92:1325-1328. doi:10.1016/j.amjcard.2003.08.017.10.1016/j.amjcard.2003.08.017
- 5. Cook s, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug eluting stent thrombosis. Circ. 2009;120:391-399. DOI: 10.1161/CIRCULATIONAHA.109.854398.10.1161/CIRCULATIONAHA.109.854398
- 6. Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of instentneoatherosclerosis after drug eluting stent implantation. Circ. 2011;123:2954-2963. doi: 10.1161/CIRCULATIONAHA.110.988436.10.1161/CIRCULATIONAHA.110.988436
- 7. Maisel WH. Unanswered questions - drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007;356:981-984. doi: 10.1056/NEJMp068305.10.1056/NEJMp068305
- 8. Van Beusekom HM, SaiaF, Zindler JD, et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J. 2007;28:974-979. doi: http://dx.doi.org/10.1093/eurheartj/ehm064.10.1093/eurheartj/ehm064
- 9. Kimura T, Morimoto T, Natsuaki M, et al. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Circ. 2012;126:1225-1236. doi: 10.1161/ CIRCULATIONAHA.112.104059.10.1161/CIRCULATIONAHA.112.104059
- 10. De Labriolle A, Bonello L, Lemesle G, et al. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare metal stents. Arch Cardiovasc Dis. 2009;102:209-217. doi: 10.1016/j. acvd.2009.01.004.
- 11. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxelcoated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circ. 2009;119:2986-2994. doi: 10.1161/CIRCULATIONAHA.108.839282.10.1161/CIRCULATIONAHA.108.839282
- 12. WentzelJJ, Gijsen FJ, Stergiopulos N, et al. Shear stress, vascular remodeling and neointimal formation. J Biomech. 2003;36:681-688. doi: http://dx.doi.org/10.1016/S0021-9290(02)00446-3.10.1016/S0021-9290(02)00446-3
- 13. Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implant bare -metal and drug eluting stents. J Am Coll Cardiol. 2011;57:1314-1322. doi: 10.1016/j.jacc.2011.01.011.10.1016/j.jacc.2011.01.011309331021376502
- 14. Maurovich-Horvath P, Hoffmann U, Vorpahl M, Masataka N, Virmani R. The napking ring: Ct signature of high risc coronary plaques. J Am Coll Cardiology Img. 2010;3:440-444. doi: 10.1016/j.jcmg.2010.02.003.10.1016/j.jcmg.2010.02.00320394906
- 15. Rathore S, Konishita Y, Terashima M, et al. A comparation of clinical presentation, angiographic patterns and outcomes of instent restenosis between bare metal and drug eluting stents. Eurointervention. 2010;5:841-846.10.4244/EIJV5I7A14120142201
- 16. Garcìa-Garcìa HM, Gogas BD, Serruys PW, Bruining N. IVUS-based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovasc Imaging. 2011;27:215-224. doi:10.1007/s10554-010-9789-7.10.1007/s10554-010-9789-7307831221327914
- 17. Liu J, Maehara A, Mintz GS, et al. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol. 2009;103:501-506. doi: 10.1016/j. amjcard.2008.10.010.
- 18. Habara M,Terashima M, Nasu K, et al. Difference of tissue characteristics between early and very late restenosis after bare metal stents implantation: an optical coherence tomography study. Circ Cardiovasc Interv. 2010;4:232-238. doi: 10.1161/CIRCINTERVENTIONS.110.959999.10.1161/CIRCINTERVENTIONS.110.95999921610225
- 19. Motoyama S, Sarai M, Harigaya H. Computed Tomographic Angiography Characteristics of Atherosclerotic Plaques Subsequently Resulting in Acute Coronary Syndrome. J Am Coll Cardiol. 2009;54:49-57. doi:10.1016/j.jacc.2009.02.068.10.1016/j.jacc.2009.02.06819555840
- 20. Benedek T, Gyongyosi M, Benedek I. Multislice Computed Tomographic Coronary Angiography for Quantitative Assessment of Culprit Lesions in Acute Coronary Syndromes. Canadian J Cardiol. 2013;29:364-371. doi:10.1016/j. cjca.2012.11.004.